Vanguard Group Inc Haemonetics Corp Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Vanguard Group Inc holds 5,179,388 shares of HAE stock, worth $323 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,179,388
Previous 5,169,269
0.2%
Holding current value
$323 Million
Previous $415 Million
2.66%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding HAE
# of Institutions
349Shares Held
55.7MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$372 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$276 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$264 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$246 Million0.06% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$159 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.2B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...